T1	Participants 402 449	cholestatic patients with chronic liver disease
T2	Participants 464 676	220 inpatients (26% chronic active hepatitis, 68% cirrhosis, 6% primary biliary cirrhosis) with stable (1 month or more) at least twofold increases in serum total and conjugated bilirubin and alkaline phosphatase
